Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34617 | 67 | 28.1 | 42% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3205 | 1558 | OCCUPATIONAL LICENSING//HOSPITALS//COMMUNITY ORIENTED PRIMARY CARE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CROSS CULTURAL COOPERATION | Author keyword | 1 | 50% | 1% | 1 |
2 | GLOBAL BUDGET PAYMENT SYSTEM | Author keyword | 1 | 50% | 1% | 1 |
3 | IDENTIFICATION OF NEEDS | Author keyword | 1 | 50% | 1% | 1 |
4 | INTERNAL MEDMETAB DIS UNIT | Address | 1 | 50% | 1% | 1 |
5 | FEDERAT HITEQ | Address | 0 | 33% | 1% | 1 |
6 | STOMACH ACID | Author keyword | 0 | 33% | 1% | 1 |
7 | CLINICAL PRACTICE GUIDELINE CPG | Author keyword | 0 | 25% | 1% | 1 |
8 | DRUG ECONOMICS | Author keyword | 0 | 20% | 1% | 1 |
9 | ADRENAL GLAND METASTASIS | Author keyword | 0 | 14% | 1% | 1 |
10 | CLINICAL APPROACHES | Author keyword | 0 | 14% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEALTH COSTS | 0 | 20% | 1% | 1 |
2 | REGULATORY PRACTICE GUIDELINES | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
The Authors Say: 'The Data Are Not So Robust because of Heterogeneity' - So, How Should I Deal with This Systematic Review? | 2011 | 4 | 4 | 25% |
Pharmaceutical epidemiology: development and implementation in France | 1999 | 1 | 22 | 18% |
SUBSTITUTABILITY OF A PROCESS INNOVATION IN MEDICAL DIAGNOSIS - SOME EMPIRICAL RESULTS | 1991 | 0 | 12 | 33% |
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials | 2001 | 152 | 57 | 4% |
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies | 2001 | 127 | 54 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERNAL MEDMETAB DIS UNIT | 1 | 50% | 1.5% | 1 |
2 | FEDERAT HITEQ | 0 | 33% | 1.5% | 1 |
3 | ICRFCLIN TRIAL SERV UNIT | 0 | 100% | 1.5% | 1 |
4 | KATTHOLI ES KLINIKUM DUISBURG | 0 | 100% | 1.5% | 1 |
5 | RADIAT THER Y PROGRAMME | 0 | 100% | 1.5% | 1 |
6 | UNITE PHARMACOGNOSIE MOL NAT BIOACT | 0 | 100% | 1.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000148136 | LAC SCALE//ORGAN LOCATION//PLICAT SUBST ABUSE TECHNOL |
2 | 0.0000137182 | JOSEPH ROSE KENNEDY ETH//HIST KNOWLEDGE//TECHNICAL REASON |
3 | 0.0000114344 | COMMUNITY ORIENTED PRIMARY CARE//SPECIALIST IN PUBLIC HEALTH//CITIZEN PROFESS |
4 | 0.0000106047 | LABOUR FORCE AND EMPLOYMENT//MIND BODY WELLNESS//MASTERS PROGRAM HOSP HLTH ADM |
5 | 0.0000103047 | DRAMA THER Y//DEONTOLOJI AD//FACILITATING ENVIRONMENT |
6 | 0.0000095868 | FRICTION COSTS//PRODUCTIVITY COSTS//COST OF SMOKING |
7 | 0.0000092804 | ACADEMIC DETAILING//DRUG UTILIZATION REVIEW//ADVANCED PULMONARY DISEASE |
8 | 0.0000089228 | DOCTOR SHOPPING BEHAVIOR//SECOND OPINION//DANA CHILDRENS HOSP PEDIAT ORTHOPED |
9 | 0.0000088745 | SUPPLIER INDUCED DEMAND//DUAL PRACTICE//PRIMARY PHYSICIAN SERVICES |
10 | 0.0000081868 | CEIP MARSEILLE//CEIP//EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO |